<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2015-01-22</publicationDate>
    
        <volume>1</volume>
        <issue>2</issue>

 
    <startPage>425</startPage>
    <endPage>428</endPage>

	    <publisherRecordId>489</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Reverse Phase High Performance Liquid Chromatographic Determination of Ezetimibe in Bulk and Pharmaceutical Formulations</title>

    <authors>
	 


      <author>
       <name>Ch. Narasimharaju BH</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>G. DevalaRao</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name> RajendranRukmani</name>

		
	<affiliationId>3</affiliationId>
      </author>
    

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">A.S.N.Pharmacy College, Burripalem Road, Tenali - 522 201 (Inda).</affiliationName>
    

		
		<affiliationName affiliationId="2">KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada - 520 010 (India). </affiliationName>
    
		
		<affiliationName affiliationId="3">Jaya College of Pharmacy, Thiruninravur - 602 024 (India).</affiliationName>
    
		
		
		
	  </affiliationsList>






    <abstract language="eng">This paper describes about validated Reverse phase High Performance Liquid Chromatographic method for determination of Ezetimibe in bulk and pharmaceutical formulations has been developed. Chromatographic separation was carried out using a mobile phase of Potassium dihydrogen phosphate buffer (containing triethylamine) and acetonitrile (55:45v/v) on a C18 –ODS –Hypersil (5 µ, 250×4.6 mm) column in isocratic mode at a flow rate of 1.5ml/minute with UV detection at 234nm. Atorvastatin calcium was used as internal standard. The chromatographic method was linear over the concentration range of 50-250ìg/ml. The Limit of Detection and Limit of Quantitation were 0.828 and 2.5 µg/ml respectively. The mean percentage purity and recovery were found to be 101.22% and 100.36% respectively. Suitable method was developed to determine Ezetimibe in bulk and pharmaceutical formulations.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol1no2/reverse-phase-high-performance-liquid-chromatographic-determination-of-ezetimibe-in-bulk-and-pharmaceutical-formulations/</fullTextUrl>

<keywords language="eng">

      
        <keyword><b> </b>RP -HPLC</keyword>
      

      
        <keyword> Ezetimibe</keyword>
      

      
        <keyword> Tablets</keyword>
      
</keywords>
  </record>
</records>